Abiopharma

Alpha Modus Completes Previously Announced Conversion of Series C Preferred Stock, Further Simplifying Capital Structure and Aligning Shareholder Interests

Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion Market

nLIGHT, Inc. Announces Participation in Eurosatory 2026 Defense Conference

Totaligent Announces Featured Speaking Role at U.S.–Taiwan Innovation Forum, Advancing Global Biologics and Medical Tourism Collaboration

Xeriants NexBoard Achieves ASTM E84 Class A Fire Rating, the Highest Rating Possible for Fire Protection

Safe Pro Executes on $742,000 U.S. Army Award Rapidly Delivering AI Edge Processing NODE and Red Cat Black Widow Drones

EPAM Systems, Inc. - EPAM and TGS Announce Strategic Collaboration to Accelerate AI Adoption at Scale in Energy Sector

Dario Presents Four Studies at American Diabetes Association Scientific Sessions Highlighting Commercial and Clinical Value of its Digital Health Platform

Calidi Biotherapeutics - Calidi Biotherapeutics Announces Investor Webinar on June 9, 2026

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Directors Interest - Tan Min Loon